BAM
JHMH

Bellevue Asset Management’s John Hancock Multifactor Healthcare ETF JHMH Stock Holding History

Bellevue Asset Management’s Portfolio JHMH Stock Details JHMH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-61,482
Closed -$2.69M – 503
2022
Q3 		$2.69M Sell
61,482
-4,429
-7% -$204K 2.09% 11
2022
Q2 		$3.01M Buy
65,911
+899
+1% +$42.2K 2.18% 11
2022
Q1 		$3.25M Sell
65,012
-1,021
-2% -$49.2K 1.99% 12
2021
Q4 		$3.42M Buy
66,033
+1,934
+3% +$95.8K 2.01% 12
2021
Q3 		$3.11M Buy
64,099
+360
+0.6% +$17.9K 1.9% 13
2021
Q2 		$3.05M Buy
63,739
+391
+0.6% +$18.2K 1.86% 13
2021
Q1 		$2.82M Buy
63,348
+1,991
+3% +$88.1K 1.75% 14
2020
Q4 		$2.78M Buy
61,357
+7,081
+13% +$297K 1.7% 14
2020
Q3 		$2.17M Buy
54,276
+2,178
+4% +$86.1K 1.52% 16
2020
Q2 		$1.96M Buy
52,098
+482
+0.9% +$17.8K 2.01% 14
2020
Q1 		$1.93M Sell
51,616
-1,731
-3% -$61.9K 2.01% 13
2019
Q4 		$1.99M Buy
+53,347
New +$1.88M 1.53% 16

Bellevue Asset Management's JHMH Position: Q4 2022 in Review

Bellevue Asset Management sold out of John Hancock Multifactor Healthcare ETF (JHMH) in Q4 2022, closing a stake of 61,482 shares — an estimated $2.69M sold.

Bellevue Asset Management first reported a position in JHMH in Q4 2019 and held it in 12 quarters. The position peaked at $3.42M in Q4 2021. 0 funds tracked by Wall St. Rank hold JHMH as of Q4 2022.

  • Bellevue Asset Management reported no remaining John Hancock Multifactor Healthcare ETF position as of Q4 2022 after selling out during the quarter.
  • Bellevue Asset Management sold 61,482 John Hancock Multifactor Healthcare ETF shares in Q4 2022, an estimated $2.69M.
  • Bellevue Asset Management first reported a position in John Hancock Multifactor Healthcare ETF in Q4 2019 and held it in 12 quarters.
  • Bellevue Asset Management's John Hancock Multifactor Healthcare ETF position peaked at $3.42M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held John Hancock Multifactor Healthcare ETF as of Q4 2022.

Based on Bellevue Asset Management's 13F filing for Q4 2022, filed 23 Jan 2023.